In the Press Barron’s: Microsoft Pushes AI in India, Snap Stock Plunges, and Other Tech News Today Open External Link
In the Press NY Times: Snap Shares Plummet After First-Quarter Guidance Disappoints Open External Link
In the Press FT: Big Tech boosts profits by $10bn with accounting change to server life estimate Open External Link
In the Press Barron’s: AbbVie Posts Revenue Beat as Humira Sales Tumble. Other Immunology Drugs Are Selling. Open External Link
In the Press CNBC: Scott Kessler, Third Bridge Technology joins ‘Closing Bell Overtime’ to talk Meta and Amazon earnings. Open External Link
In the Press CNBC: Qualcomm reporting earnings beating on the top and bottom lines Open External Link
In the Press Barron’s: Wall Street Analysts Love Microsoft’s ‘Masterpiece’ Results. Why the Stock Market Doesn’t. Open External Link
In the Press Fierce Pharma: GSK confirms Arexvy is a blockbuster but says the RSV battle has just begun Open External Link
In the Press Bloomberg: Match Reports Decline in Paying Tinder Users, Announces Buyback Open External Link
In the Press Fierce Pharma: After ‘bad launch’ remark by CEO, Pfizer’s RSV vaccine gains traction in Q4. How will it fare in latest round of GSK showdown? Open External Link
In the Press Reuters: Marathon Petroleum tops quarterly profit on upbeat margins, lower costs Open External Link
In the Press Barron’s: Intel Stock Had Its Worst Day in Years After Earnings. What Wall Street Is Saying. Open External Link
In the Press NY Times: Airlines Hoping for More Boeing Jets Could Be Waiting Awhile Open External Link